Cargando…
Antiviral Pharmacology: A Standardized Patient Case for Preclinical Medical Students
INTRODUCTION: Pharmacology is an important learning topic in preclinical medical education. Simulated patient encounters allow students to apply basic science knowledge in a clinical setting and have been useful in previous studies of pharmacology education. We developed a standardized patient (SP)...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Association of American Medical Colleges
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038986/ https://www.ncbi.nlm.nih.gov/pubmed/35539004 http://dx.doi.org/10.15766/mep_2374-8265.11242 |
_version_ | 1784694022358433792 |
---|---|
author | Jones, Michael K. Gupta, Karisma R. Peters, Timothy R. Beardsley, James R. Jackson, Jennifer M. |
author_facet | Jones, Michael K. Gupta, Karisma R. Peters, Timothy R. Beardsley, James R. Jackson, Jennifer M. |
author_sort | Jones, Michael K. |
collection | PubMed |
description | INTRODUCTION: Pharmacology is an important learning topic in preclinical medical education. Simulated patient encounters allow students to apply basic science knowledge in a clinical setting and have been useful in previous studies of pharmacology education. We developed a standardized patient (SP) encounter to reinforce antiviral pharmacology content for first-year medical students. METHODS: Students were instructed to recommend a medication for shingles during an SP encounter and to answer questions from the SP on mechanism of action and adverse effects. Students then attended a large-group debrief session. Following the activity, students evaluated the exercise through a voluntary survey. For knowledge assessment, students were randomized into two groups to complete three multiple-choice questions either before or after the learning activity. RESULTS: In 2020 and 2021, 144 and 145 students, respectively, participated. In 2020, there was no significant difference in the proportion of correct answers between the pre- and postsimulation groups (p > .05). In 2021, the postsimulation group significantly outperformed the presimulation group in knowledge of mechanism of action (p < .01) and adverse effects (p < .01), but no difference was seen between the groups regarding medication selection (p = .27). Most learners assessed the instructional design as effective for the tasks assigned. DISCUSSION: This SP activity provided an opportunity for early medical students to practice integrating antiviral pharmacology knowledge into a patient encounter and was well received by learners. The instructional method offers a clinically relevant approach for reinforcing pharmacology knowledge for preclinical medical students. |
format | Online Article Text |
id | pubmed-9038986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Association of American Medical Colleges |
record_format | MEDLINE/PubMed |
spelling | pubmed-90389862022-05-09 Antiviral Pharmacology: A Standardized Patient Case for Preclinical Medical Students Jones, Michael K. Gupta, Karisma R. Peters, Timothy R. Beardsley, James R. Jackson, Jennifer M. MedEdPORTAL Original Publication INTRODUCTION: Pharmacology is an important learning topic in preclinical medical education. Simulated patient encounters allow students to apply basic science knowledge in a clinical setting and have been useful in previous studies of pharmacology education. We developed a standardized patient (SP) encounter to reinforce antiviral pharmacology content for first-year medical students. METHODS: Students were instructed to recommend a medication for shingles during an SP encounter and to answer questions from the SP on mechanism of action and adverse effects. Students then attended a large-group debrief session. Following the activity, students evaluated the exercise through a voluntary survey. For knowledge assessment, students were randomized into two groups to complete three multiple-choice questions either before or after the learning activity. RESULTS: In 2020 and 2021, 144 and 145 students, respectively, participated. In 2020, there was no significant difference in the proportion of correct answers between the pre- and postsimulation groups (p > .05). In 2021, the postsimulation group significantly outperformed the presimulation group in knowledge of mechanism of action (p < .01) and adverse effects (p < .01), but no difference was seen between the groups regarding medication selection (p = .27). Most learners assessed the instructional design as effective for the tasks assigned. DISCUSSION: This SP activity provided an opportunity for early medical students to practice integrating antiviral pharmacology knowledge into a patient encounter and was well received by learners. The instructional method offers a clinically relevant approach for reinforcing pharmacology knowledge for preclinical medical students. Association of American Medical Colleges 2022-04-26 /pmc/articles/PMC9038986/ /pubmed/35539004 http://dx.doi.org/10.15766/mep_2374-8265.11242 Text en © 2022 Jones et al. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access publication distributed under the terms of the Creative Commons Attribution-NonCommercial (https://creativecommons.org/licenses/by-nc/4.0/) license. |
spellingShingle | Original Publication Jones, Michael K. Gupta, Karisma R. Peters, Timothy R. Beardsley, James R. Jackson, Jennifer M. Antiviral Pharmacology: A Standardized Patient Case for Preclinical Medical Students |
title | Antiviral Pharmacology: A Standardized Patient Case for Preclinical Medical Students |
title_full | Antiviral Pharmacology: A Standardized Patient Case for Preclinical Medical Students |
title_fullStr | Antiviral Pharmacology: A Standardized Patient Case for Preclinical Medical Students |
title_full_unstemmed | Antiviral Pharmacology: A Standardized Patient Case for Preclinical Medical Students |
title_short | Antiviral Pharmacology: A Standardized Patient Case for Preclinical Medical Students |
title_sort | antiviral pharmacology: a standardized patient case for preclinical medical students |
topic | Original Publication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038986/ https://www.ncbi.nlm.nih.gov/pubmed/35539004 http://dx.doi.org/10.15766/mep_2374-8265.11242 |
work_keys_str_mv | AT jonesmichaelk antiviralpharmacologyastandardizedpatientcaseforpreclinicalmedicalstudents AT guptakarismar antiviralpharmacologyastandardizedpatientcaseforpreclinicalmedicalstudents AT peterstimothyr antiviralpharmacologyastandardizedpatientcaseforpreclinicalmedicalstudents AT beardsleyjamesr antiviralpharmacologyastandardizedpatientcaseforpreclinicalmedicalstudents AT jacksonjenniferm antiviralpharmacologyastandardizedpatientcaseforpreclinicalmedicalstudents |